Distributing since 1889 • Employee Owned for Better Service
Your 1st Choice!
Sign In
Quick Search:

Shopping Cart Cart |  My Account |  View Printable Page Print
Product Detail

Nelson's Pediatric Antimicrobial Therapy 2022

Bradley, John S. MD
Nelsons Pediatric Antimicrobial Therapy 2022 Cover Image
Pricing & Availability
Available: 0
List Price:$36.95

Email this title to a friend Email this title to a friend
Printer friendly version Printer friendly version
Book Information
Edition: 28th
Publisher: American Academy of Pediatrics
ISBN: 1-61002-564-4 (1610025644)
ISBN-13: 978-1-61002-564-5 (9781610025645)
New Edition: 1-61002-650-0
Old Edition: 1-61002-444-3
Format: Hndbk/Pktbk/Tables
Binding: Softcover
Copyright: 2022
Publish Date: 03/22
Volume: 2022
Weight: 0.67 Lbs.
Pages: 366
Subject Class: PED (Pediatrics)
Remarks:
A New Edition of this Title is Available
Return Policy: Returns accepted up to 12 months provided no other recalls or return restrictions apply.
Contributing Authors: View
 
Class Specifications
ISSN Series: Nelson's Pediatric Antimicrobial Therapy
Discipline: Pharmacology
Subject Definition: Antibiotics-Therapeutic Use-Handbooks; Child
NLM Class: QV 39
LC Class: RJ53
Abstract: Completely updated and revised, the 28th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children.For each disease, the authors provide a commentary to help select the best of all antimicrobial choices.Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.Updated recommendations on acute hematogenous osteomyelitis, based on newly published guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, including information on a decrease in the incidence of MRSA infections, allowing the recommendation of cefazolin, again, in empiric therapy for most pediatric bone infections.Updated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 2021.."2022.Ceftazidime/avibactam now preferred over fluoroquinolones for treatment of Klebsiella pneumoniae carbapenemase.."producing enteric bacilli, if susceptible.

Follow Matthews Book Co. on:
Follow Matthews Book Co. on Twitter

Copyright © 2001-2024 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews Privacy Statement